A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men
Clinical trial NCT05857878 · COMPLETED
Trial details
- NCT number
- NCT05857878
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-23
- Primary completion
- 2024-06-06
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.